Literature DB >> 9655893

Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine.

R Tao1, Z Ma, S B Auerbach.   

Abstract

Regulation of serotonin (5-HT) release may be altered during the development of opioid tolerance and dependency. To test this hypothesis, changes in extracellular 5-HT during prolonged administration of morphine were determined by microdialysis in the dorsal raphe nucleus (DRN) of freely behaving rats. Morphine or placebo pellets were implanted s.c. As compared to placebo, morphine pellets induced a sustained, approximately 50% increase in DRN 5-HT and a significant elevation in hot plate latency during the 12-hr period after implantation. One week later DRN 5-HT had returned to control levels, and implanting additional morphine pellets had no effect on 5-HT or hot plate latency. One day after removing the pellets from rats exposed to morphine for 2 wk, acute challenge with morphine (20 mg/kg, s.c.) had a significantly smaller effect on 5-HT in the DRN as compared to the placebo treatment group. Administration of naltrexone to rats implanted with morphine pellets for 2 wk induced signs of withdrawal and a significant decrease in DRN 5-HT. These results suggest that the regulation of 5-HT release is altered during the development of tolerance to morphine. Thus, DRN 5-HT may be one of the factors involved in the changes in physiology and behavioral state during opioid withdrawal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655893

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  NO-ergic neurons of the cervical nucleus of the rat brain in normal conditions and after administration of opiates.

Authors:  I V Dyuizen; I I Deridovich; R A Kurbatskii; V V Shorin
Journal:  Neurosci Behav Physiol       Date:  2004-07

2.  Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.

Authors:  Tzung Lieh Yeh; Kao Chin Chen; Shih-Hsien Lin; I Hui Lee; Po See Chen; Wei Jen Yao; Sheng-Yu Lee; Yen Kuang Yang; Ru-Band Lu; Mei-Hsiu Liao; Nan-Tsing Chiu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-01       Impact factor: 4.530

3.  The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.

Authors:  Steven M Graves; Amanda L Persons; Jennifer L Riddle; T Celeste Napier
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

4.  Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus.

Authors:  J W Lunden; L G Kirby
Journal:  Neuroscience       Date:  2013-09-20       Impact factor: 3.590

5.  Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats.

Authors:  D R Staub; J W Lunden; A M Cathel; E L Dolben; L G Kirby
Journal:  Psychoneuroendocrinology       Date:  2011-11-01       Impact factor: 4.905

6.  Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.

Authors:  Harshini Neelakantan; Erica D Holliday; Robert G Fox; Sonja J Stutz; Sandra D Comer; Margaret Haney; Noelle C Anastasio; F Gerard Moeller; Kathryn A Cunningham
Journal:  ACS Chem Neurosci       Date:  2017-02-13       Impact factor: 4.418

7.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

8.  Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Authors:  M Wu; P Sahbaie; M Zheng; R Lobato; D Boison; J D Clark; G Peltz
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

9.  From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Authors:  Larry F Chu; De-Yong Liang; Xiangqi Li; Peyman Sahbaie; Nicole D'arcy; Guochun Liao; Gary Peltz; J David Clark
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

10.  Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward.

Authors:  Zhong-Qiu Zhao; Yong-Jing Gao; Yan-Gang Sun; Cheng-Shui Zhao; Robert W Gereau; Zhou-Feng Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.